Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Adoptive immunotherapy). Showing records 1 – 30 of 55 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

▼ Search Limiters

1. Hu, Hong-Ming. Priming of therapeutic T cells for adoptive immunotherapy.

Degree: PhD, 2003, Oregon Health Sciences University

Subjects/Keywords: Immunotherapy; Adoptive

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hu, H. (2003). Priming of therapeutic T cells for adoptive immunotherapy. (Doctoral Dissertation). Oregon Health Sciences University. Retrieved from doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146

Chicago Manual of Style (16th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Doctoral Dissertation, Oregon Health Sciences University. Accessed December 13, 2019. doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

MLA Handbook (7th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Web. 13 Dec 2019.

Vancouver:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Internet] [Doctoral dissertation]. Oregon Health Sciences University; 2003. [cited 2019 Dec 13]. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

Council of Science Editors:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Doctoral Dissertation]. Oregon Health Sciences University; 2003. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146


McMaster University

2. Bastin, Donald. Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting.

Degree: MSc, 2017, McMaster University

The adoptive transfer of cancer-specific T-cells has demonstrated success as a novel treatment strategy in some hematological malignancies but this approach has not yet achieved… (more)

Subjects/Keywords: Oncolytic Virus; Adoptive Cell Thearpy; Immunotherapy; Cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bastin, D. (2017). Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/22220

Chicago Manual of Style (16th Edition):

Bastin, Donald. “Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting.” 2017. Masters Thesis, McMaster University. Accessed December 13, 2019. http://hdl.handle.net/11375/22220.

MLA Handbook (7th Edition):

Bastin, Donald. “Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting.” 2017. Web. 13 Dec 2019.

Vancouver:

Bastin D. Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting. [Internet] [Masters thesis]. McMaster University; 2017. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/11375/22220.

Council of Science Editors:

Bastin D. Overcoming Limitations in Adoptive Cell Therapies with Dual Specific T-cells and Oncolytic Viral Boosting. [Masters Thesis]. McMaster University; 2017. Available from: http://hdl.handle.net/11375/22220

3. Kora, Hafid. Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches.

Degree: Docteur es, Sciences de la vie et de la sante, 2017, Normandie

 L’immunothérapie représente une avancée majeure dans la prise en charge des patients atteints de cancer. L’utilisation thérapeutique récente des anticorps anti-"checkpoints", qui renforcent la réponse… (more)

Subjects/Keywords: Immunologie; Cancers colorectaux; Immunothérapie cellulaire; Cellules présentatrices d'antigènes; Immunothérapie adoptive; Immunology; Colorectal neoplasms; Cellular immunotherapy; Antigen presenting cells; Adoptive Immunotherapy; 616.994

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kora, H. (2017). Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches. (Doctoral Dissertation). Normandie. Retrieved from http://www.theses.fr/2017NORMR092

Chicago Manual of Style (16th Edition):

Kora, Hafid. “Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches.” 2017. Doctoral Dissertation, Normandie. Accessed December 13, 2019. http://www.theses.fr/2017NORMR092.

MLA Handbook (7th Edition):

Kora, Hafid. “Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches.” 2017. Web. 13 Dec 2019.

Vancouver:

Kora H. Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches. [Internet] [Doctoral dissertation]. Normandie; 2017. [cited 2019 Dec 13]. Available from: http://www.theses.fr/2017NORMR092.

Council of Science Editors:

Kora H. Caractérisation de peptides HLA-A2.1 restreints immunogènes dans le cadre des cancers colorectaux à instabilité microsatellitaire : développement de nouvelles approches d'immunothérapie cellulaire spécifique : Characterization of restricted immunogene HLA-A2.1 peptides within the framework of the colorectal cancers with microsatellite instability : development of new specific cellular immunotherapy approaches. [Doctoral Dissertation]. Normandie; 2017. Available from: http://www.theses.fr/2017NORMR092

4. Friedman, Kevin M. Augmenting the effector phase of adoptive T cell immunotherapy of cancer.

Degree: PhD, 2009, Oregon Health Sciences University

Subjects/Keywords: Immunotherapy, Adoptive; Neoplasms; Immune System

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Friedman, K. M. (2009). Augmenting the effector phase of adoptive T cell immunotherapy of cancer. (Doctoral Dissertation). Oregon Health Sciences University. Retrieved from doi:10.6083/M4QV3JHF ; http://digitalcommons.ohsu.edu/etd/358

Chicago Manual of Style (16th Edition):

Friedman, Kevin M. “Augmenting the effector phase of adoptive T cell immunotherapy of cancer.” 2009. Doctoral Dissertation, Oregon Health Sciences University. Accessed December 13, 2019. doi:10.6083/M4QV3JHF ; http://digitalcommons.ohsu.edu/etd/358.

MLA Handbook (7th Edition):

Friedman, Kevin M. “Augmenting the effector phase of adoptive T cell immunotherapy of cancer.” 2009. Web. 13 Dec 2019.

Vancouver:

Friedman KM. Augmenting the effector phase of adoptive T cell immunotherapy of cancer. [Internet] [Doctoral dissertation]. Oregon Health Sciences University; 2009. [cited 2019 Dec 13]. Available from: doi:10.6083/M4QV3JHF ; http://digitalcommons.ohsu.edu/etd/358.

Council of Science Editors:

Friedman KM. Augmenting the effector phase of adoptive T cell immunotherapy of cancer. [Doctoral Dissertation]. Oregon Health Sciences University; 2009. Available from: doi:10.6083/M4QV3JHF ; http://digitalcommons.ohsu.edu/etd/358


Virginia Commonwealth University

5. Cha, Esther. MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS.

Degree: MS, Physiology, 2009, Virginia Commonwealth University

 Successful adoptive immunotherapy (AIT) for cancer relies on the infusion of in vitro expanded, tumor-reactive lymphocytes with a goal of generating productive tumor immunity. Previously,… (more)

Subjects/Keywords: Adoptive Immunotherapy; Life Sciences; Physiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cha, E. (2009). MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS. (Thesis). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/1905

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cha, Esther. “MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS.” 2009. Thesis, Virginia Commonwealth University. Accessed December 13, 2019. https://scholarscompass.vcu.edu/etd/1905.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cha, Esther. “MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS.” 2009. Web. 13 Dec 2019.

Vancouver:

Cha E. MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS. [Internet] [Thesis]. Virginia Commonwealth University; 2009. [cited 2019 Dec 13]. Available from: https://scholarscompass.vcu.edu/etd/1905.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cha E. MARRYING IMMUNOTHERAPY AND CHEMOTHERAPY: A CANCER THERAPY BASED ON T LYMPHOCYTE EXPANSION AUGMENTED BY ALTERNATE GAMMA CHAIN CYTOKINES AND GEMCITABINE-MEDIATED INHIBITION OF MYELOID DERIVED SUPPRESSOR CELLS. [Thesis]. Virginia Commonwealth University; 2009. Available from: https://scholarscompass.vcu.edu/etd/1905

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

6. Chaudhry, Kajal. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.

Degree: Graduate School of Biomedical Engineering, 2018, University of New South Wales

 A patient’s own T cells can be genetically modified and amplified in the laboratory to target antigens expressed ontumour cells through the introduction of chimeric… (more)

Subjects/Keywords: T cells; Adoptive immunotherapy; Chimeric antigen receptor; NK cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chaudhry, K. (2018). The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/61998

Chicago Manual of Style (16th Edition):

Chaudhry, Kajal. “The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.” 2018. Doctoral Dissertation, University of New South Wales. Accessed December 13, 2019. http://handle.unsw.edu.au/1959.4/61998.

MLA Handbook (7th Edition):

Chaudhry, Kajal. “The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.” 2018. Web. 13 Dec 2019.

Vancouver:

Chaudhry K. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2019 Dec 13]. Available from: http://handle.unsw.edu.au/1959.4/61998.

Council of Science Editors:

Chaudhry K. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/61998


University of Minnesota

7. Litterman, Adam. Overcoming Obstacles to Glioma Immunotherapy.

Degree: PhD, Microbiology, Immunology and Cancer Biology, 2014, University of Minnesota

 Glioma is a type of malignant tumor of the non-neuronal cells of the central nervous system, the glia. These tumors are the most common malignant… (more)

Subjects/Keywords: Adoptive transfer; Cancer vaccines; Glioma; Immunotherapy; T cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Litterman, A. (2014). Overcoming Obstacles to Glioma Immunotherapy. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/191307

Chicago Manual of Style (16th Edition):

Litterman, Adam. “Overcoming Obstacles to Glioma Immunotherapy.” 2014. Doctoral Dissertation, University of Minnesota. Accessed December 13, 2019. http://hdl.handle.net/11299/191307.

MLA Handbook (7th Edition):

Litterman, Adam. “Overcoming Obstacles to Glioma Immunotherapy.” 2014. Web. 13 Dec 2019.

Vancouver:

Litterman A. Overcoming Obstacles to Glioma Immunotherapy. [Internet] [Doctoral dissertation]. University of Minnesota; 2014. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/11299/191307.

Council of Science Editors:

Litterman A. Overcoming Obstacles to Glioma Immunotherapy. [Doctoral Dissertation]. University of Minnesota; 2014. Available from: http://hdl.handle.net/11299/191307


University of Illinois – Urbana-Champaign

8. Thomas, Diana L. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.

Degree: PhD, 0323, 2011, University of Illinois – Urbana-Champaign

Adoptive immunotherapy and oncolytic virotherapy are two promising strategies for treating primary and metastatic malignant brain tumors. We demonstrate the ability of adoptively transferred tumor-specific… (more)

Subjects/Keywords: brain tumors; immunotherapy; oncolytic virotherapy; Melanoma; Adoptive T Cell Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thomas, D. L. (2011). Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/18568

Chicago Manual of Style (16th Edition):

Thomas, Diana L. “Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.” 2011. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed December 13, 2019. http://hdl.handle.net/2142/18568.

MLA Handbook (7th Edition):

Thomas, Diana L. “Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors.” 2011. Web. 13 Dec 2019.

Vancouver:

Thomas DL. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2011. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/2142/18568.

Council of Science Editors:

Thomas DL. Evaluation of Adoptive T Cell Therapy and Oncolytic Virotherapy for Treatment of Brain Tumors. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2011. Available from: http://hdl.handle.net/2142/18568


Johannes Gutenberg Universität Mainz

9. Zupke, Oliver. Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy.

Degree: 2012, Johannes Gutenberg Universität Mainz

 Dendritic cells (DCs) are the most potent cell type for capture, processing, and presentation of antigens. They are able to activate naïve T cells as… (more)

Subjects/Keywords: Nanopartikel, Dendritische Zellen, T-Lymphozyten, Adoptive Immuntherapie; Nanoparticles, dendritic cells, T lymphocytes, adoptive immunotherapy; Life sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zupke, O. (2012). Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2012/3288/

Chicago Manual of Style (16th Edition):

Zupke, Oliver. “Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy.” 2012. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 13, 2019. http://ubm.opus.hbz-nrw.de/volltexte/2012/3288/.

MLA Handbook (7th Edition):

Zupke, Oliver. “Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy.” 2012. Web. 13 Dec 2019.

Vancouver:

Zupke O. Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2012. [cited 2019 Dec 13]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2012/3288/.

Council of Science Editors:

Zupke O. Nanoparticles for efficient uptake by human dendritic cells and T lymphocytes to be used in adoptive immunotherapy. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2012. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2012/3288/


Johannes Gutenberg Universität Mainz

10. Gergely, Kerstin Marlene. Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen.

Degree: 2012, Johannes Gutenberg Universität Mainz

Klinische Manifestationen einer Cytomegalovirus (CMV)-Infektion gefährden den therapeutischen Erfolg der hämatopoetischen Stammzelltransplantation (HSCT). Dabei stellt insbesondere die Reaktivierung von latentem CMV im HSCT-Rezipienten das häufigste… (more)

Subjects/Keywords: therapeutische Vakzinierung, adoptive Immuntherapie, mCMV, murine Cytomegalovirus, Dense Bodies; therapeutic vaccination, adoptive immunotherapy, mCMV, murine cytomegalovirus, dense bodies; Life sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gergely, K. M. (2012). Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2013/3312/

Chicago Manual of Style (16th Edition):

Gergely, Kerstin Marlene. “Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen.” 2012. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 13, 2019. http://ubm.opus.hbz-nrw.de/volltexte/2013/3312/.

MLA Handbook (7th Edition):

Gergely, Kerstin Marlene. “Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen.” 2012. Web. 13 Dec 2019.

Vancouver:

Gergely KM. Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2012. [cited 2019 Dec 13]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3312/.

Council of Science Editors:

Gergely KM. Präklinische Evaluierung von therapeutischer Vakzinierung zur Effizienzsteigerung der adoptiven Immuntherapie von Cytomegalovirus-Erkrankungen. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2012. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2013/3312/


Universidade do Rio Grande do Sul

11. Silva, Maria Aparecida Lima da. O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK).

Degree: 2012, Universidade do Rio Grande do Sul

Infusões de células T e células NK (Natural Killer) de sangue periférico estão sendo realizadas para tratamento de malignidades. Os linfócitos propagados ex vivo, em… (more)

Subjects/Keywords: Hypoxia; Anóxia; Linfócitos T; T cells; Células matadoras naturais; NK cells; Imunoterapia; Adoptive immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Silva, M. A. L. d. (2012). O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK). (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/60761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Silva, Maria Aparecida Lima da. “O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK).” 2012. Thesis, Universidade do Rio Grande do Sul. Accessed December 13, 2019. http://hdl.handle.net/10183/60761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Silva, Maria Aparecida Lima da. “O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK).” 2012. Web. 13 Dec 2019.

Vancouver:

Silva MALd. O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK). [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2012. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/10183/60761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Silva MALd. O impacto da hipóxia na expansão in vitro de células T e Natural Killer (NK). [Thesis]. Universidade do Rio Grande do Sul; 2012. Available from: http://hdl.handle.net/10183/60761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Johannes Gutenberg Universität Mainz

12. Mades, Andreas. Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten.

Degree: 2015, Johannes Gutenberg Universität Mainz

Interleukin 15 (IL-15) gilt als eines der vielversprechendsten zukünftigen Medikamente für die Krebstherapie. Es fördert die Proliferation, Persistenz und Funktion von CD8+ T-Zellen und vermittelt… (more)

Subjects/Keywords: Interleukin 15, adoptiver T-Zelltransfer, Immuntherapie; interleukin 15 adoptive T cell transfer, immunotherapy; Life sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mades, A. (2015). Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten. (Doctoral Dissertation). Johannes Gutenberg Universität Mainz. Retrieved from http://ubm.opus.hbz-nrw.de/volltexte/2015/4184/

Chicago Manual of Style (16th Edition):

Mades, Andreas. “Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten.” 2015. Doctoral Dissertation, Johannes Gutenberg Universität Mainz. Accessed December 13, 2019. http://ubm.opus.hbz-nrw.de/volltexte/2015/4184/.

MLA Handbook (7th Edition):

Mades, Andreas. “Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten.” 2015. Web. 13 Dec 2019.

Vancouver:

Mades A. Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten. [Internet] [Doctoral dissertation]. Johannes Gutenberg Universität Mainz; 2015. [cited 2019 Dec 13]. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2015/4184/.

Council of Science Editors:

Mades A. Optimierte biologische Aktivität allo- und tumorreaktiver CD8-+-T-Lymphozyten im humanisierten Mausmodell durch IL-15-Superagonisten. [Doctoral Dissertation]. Johannes Gutenberg Universität Mainz; 2015. Available from: http://ubm.opus.hbz-nrw.de/volltexte/2015/4184/


UCLA

13. Zah, Eugenia. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.

Degree: Chemical Engineering, 2018, UCLA

 The recent FDA approval of CD19 chimeric antigen receptor (CAR) adoptive T-cell therapy for B-cell leukemias serves to highlight CAR-T cell therapy as a promising… (more)

Subjects/Keywords: Chemical engineering; Immunology; Adoptive T-cell therapy; Cancer immunotherapy; Chimeric antigen receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zah, E. (2018). Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/019427pr

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zah, Eugenia. “Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.” 2018. Thesis, UCLA. Accessed December 13, 2019. http://www.escholarship.org/uc/item/019427pr.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zah, Eugenia. “Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.” 2018. Web. 13 Dec 2019.

Vancouver:

Zah E. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. [Internet] [Thesis]. UCLA; 2018. [cited 2019 Dec 13]. Available from: http://www.escholarship.org/uc/item/019427pr.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zah E. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. [Thesis]. UCLA; 2018. Available from: http://www.escholarship.org/uc/item/019427pr

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

14. Basu, Debasmita. EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY.

Degree: MS, Microbiology & Immunology, 2010, Virginia Commonwealth University

 Myeloid derived suppressor cells (MDSCs) are heterogeneous population of immature cells at various stages of differentiation, characterized by the presence of CD11b and Gr1 in… (more)

Subjects/Keywords: sequential common gamma chain cytokines; MDSC; Adoptive Immunotherapy; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Basu, D. (2010). EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY. (Thesis). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/2198

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Basu, Debasmita. “EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY.” 2010. Thesis, Virginia Commonwealth University. Accessed December 13, 2019. https://scholarscompass.vcu.edu/etd/2198.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Basu, Debasmita. “EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY.” 2010. Web. 13 Dec 2019.

Vancouver:

Basu D. EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY. [Internet] [Thesis]. Virginia Commonwealth University; 2010. [cited 2019 Dec 13]. Available from: https://scholarscompass.vcu.edu/etd/2198.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Basu D. EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY. [Thesis]. Virginia Commonwealth University; 2010. Available from: https://scholarscompass.vcu.edu/etd/2198

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

15. Umana, Juan Mauricio. Development of TCR-engineered iNKT cells for Cancer Immunotherapy.

Degree: 2018, University of Toronto

Invariant Natural Killer T (iNKT) cells are innate T cells that respond to lipid antigens presented by the molecule CD1d. Activated iNKT cells rapidly produce… (more)

Subjects/Keywords: adoptive cell therapy; cancer; Immunotherapy; iNKT cells; innate immuninty; TCR-engineering; 0982

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Umana, J. M. (2018). Development of TCR-engineered iNKT cells for Cancer Immunotherapy. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/91393

Chicago Manual of Style (16th Edition):

Umana, Juan Mauricio. “Development of TCR-engineered iNKT cells for Cancer Immunotherapy.” 2018. Masters Thesis, University of Toronto. Accessed December 13, 2019. http://hdl.handle.net/1807/91393.

MLA Handbook (7th Edition):

Umana, Juan Mauricio. “Development of TCR-engineered iNKT cells for Cancer Immunotherapy.” 2018. Web. 13 Dec 2019.

Vancouver:

Umana JM. Development of TCR-engineered iNKT cells for Cancer Immunotherapy. [Internet] [Masters thesis]. University of Toronto; 2018. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/1807/91393.

Council of Science Editors:

Umana JM. Development of TCR-engineered iNKT cells for Cancer Immunotherapy. [Masters Thesis]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/91393


University of Illinois – Urbana-Champaign

16. Soto, Carolina. Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma.

Degree: PhD, 0323, 2013, University of Illinois – Urbana-Champaign

 Over the past few decades, our knowledge of tumor immunology and the role antitumor immune responses play in tumor recognition and eradication has greatly increased… (more)

Subjects/Keywords: Cancer Immunotherapy; Tumor Targeting; T cell receptors (TCR); T cell; Melanoma; Adoptive Cell Therapy; Glioma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Soto, C. (2013). Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/42476

Chicago Manual of Style (16th Edition):

Soto, Carolina. “Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma.” 2013. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed December 13, 2019. http://hdl.handle.net/2142/42476.

MLA Handbook (7th Edition):

Soto, Carolina. “Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma.” 2013. Web. 13 Dec 2019.

Vancouver:

Soto C. Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2013. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/2142/42476.

Council of Science Editors:

Soto C. Adoptive cell therapy using primary T lymphocytes with genetically engineered T cell receptors against melanoma and glioma. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2013. Available from: http://hdl.handle.net/2142/42476


Duke University

17. Lin, Regina. Targeting T Cells for the Immune-Modulation of Human Diseases .

Degree: 2015, Duke University

  Dysregulated inflammation underlies the pathogenesis of a myriad of human diseases ranging from cancer to autoimmunity. As coordinators, executers and sentinels of host immunity,… (more)

Subjects/Keywords: Immunology; Adoptive T cell transfer; Autoimmune diseases; Chimeric antigen receptor; Immunotherapy; microRNA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lin, R. (2015). Targeting T Cells for the Immune-Modulation of Human Diseases . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/9824

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lin, Regina. “Targeting T Cells for the Immune-Modulation of Human Diseases .” 2015. Thesis, Duke University. Accessed December 13, 2019. http://hdl.handle.net/10161/9824.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lin, Regina. “Targeting T Cells for the Immune-Modulation of Human Diseases .” 2015. Web. 13 Dec 2019.

Vancouver:

Lin R. Targeting T Cells for the Immune-Modulation of Human Diseases . [Internet] [Thesis]. Duke University; 2015. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/10161/9824.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lin R. Targeting T Cells for the Immune-Modulation of Human Diseases . [Thesis]. Duke University; 2015. Available from: http://hdl.handle.net/10161/9824

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Duke University

18. Suryadevara, Carter. CAR T-cell Immunotherapy for Brain Tumors .

Degree: 2017, Duke University

  Glioblastoma (GBM) is the most common and deadly primary malignant brain tumor. Despite an aggressive multimodal standard of care, prognoses and patient quality of… (more)

Subjects/Keywords: Immunology; Biology; Neurosciences; adoptive cell transfer; Brain Tumor; Cancer; Glioblastoma; Immunotherapy; T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Suryadevara, C. (2017). CAR T-cell Immunotherapy for Brain Tumors . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/14561

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Suryadevara, Carter. “CAR T-cell Immunotherapy for Brain Tumors .” 2017. Thesis, Duke University. Accessed December 13, 2019. http://hdl.handle.net/10161/14561.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Suryadevara, Carter. “CAR T-cell Immunotherapy for Brain Tumors .” 2017. Web. 13 Dec 2019.

Vancouver:

Suryadevara C. CAR T-cell Immunotherapy for Brain Tumors . [Internet] [Thesis]. Duke University; 2017. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/10161/14561.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Suryadevara C. CAR T-cell Immunotherapy for Brain Tumors . [Thesis]. Duke University; 2017. Available from: http://hdl.handle.net/10161/14561

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

19. Chen, Branson. Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy.

Degree: 2018, University of Toronto

Chemotherapy resistance in acute myeloid leukemia (AML) is a prevalent problem that contributes to disease relapse and patient death; hence, novel therapies are needed to… (more)

Subjects/Keywords: acute myeloid leukemia; adoptive cellular therapy; cancer immunotherapy; chemotherapy; CRISPR screen; 0982

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, B. (2018). Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/97653

Chicago Manual of Style (16th Edition):

Chen, Branson. “Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy.” 2018. Masters Thesis, University of Toronto. Accessed December 13, 2019. http://hdl.handle.net/1807/97653.

MLA Handbook (7th Edition):

Chen, Branson. “Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy.” 2018. Web. 13 Dec 2019.

Vancouver:

Chen B. Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy. [Internet] [Masters thesis]. University of Toronto; 2018. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/1807/97653.

Council of Science Editors:

Chen B. Exploring Approaches to Enhance the Anti-Leukemic Function of Double Negative T Cell Therapy. [Masters Thesis]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/97653

20. Taha, Mohammed. L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells.

Degree: Docteur es, Pathologie humaine. Oncologie, 2018, Aix Marseille Université

Les cellules Natural Killer (NK) sont jouent un rôle essentiel dans la surveillance des hémopathies malignes. Cependant, les cellules tumorales développent des mécanismes immunosuppresseurs pour… (more)

Subjects/Keywords: Cellules NK; Immunothérapie Adoptive; Pumilio2; Proteine de liaison a l`ARN; Leucémie myéloide aigue; NK cells; Acute myeloid leukemia; Adoptive Immunotherapy; Pumilio2; RNA-Binding Protein

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Taha, M. (2018). L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2018AIXM0233

Chicago Manual of Style (16th Edition):

Taha, Mohammed. “L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells.” 2018. Doctoral Dissertation, Aix Marseille Université. Accessed December 13, 2019. http://www.theses.fr/2018AIXM0233.

MLA Handbook (7th Edition):

Taha, Mohammed. “L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells.” 2018. Web. 13 Dec 2019.

Vancouver:

Taha M. L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells. [Internet] [Doctoral dissertation]. Aix Marseille Université 2018. [cited 2019 Dec 13]. Available from: http://www.theses.fr/2018AIXM0233.

Council of Science Editors:

Taha M. L'utilisation de cellules natural killer (NK) comme outil thérapeutique : étude clinique de phase 1 de perfusion de cellules NK du donneur après HSCT : Annexe : Pumilio 2, une protéine de liaison à l'ARN surexprimée dans les cellules NK de patients atteints de LAM, réprime les fonctions des cellules NK : Use of natural killer cells (NK) as a therapeutic tool : phase I clinical study of NK donor lymphocyte infusion after HSCT : Annex : Pumilio 2, a RNA binding protein upregulated in NK cells from AML patients, represses functions of NK cells. [Doctoral Dissertation]. Aix Marseille Université 2018. Available from: http://www.theses.fr/2018AIXM0233

21. Mahnke, Yolanda Dagmar. A novel model system for the study of anti-tumour T-cell memory.

Degree: PhD, 2001, Open University

 An adoptive immunotherapy (ADI) protocol was developed where the fate and requirements of longterm persisting memory T-cells can be monitored. Anti-tumour immune peritoneal exudate cells… (more)

Subjects/Keywords: 572.8; Adoptive immunotherapy; T-cells; T-lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mahnke, Y. D. (2001). A novel model system for the study of anti-tumour T-cell memory. (Doctoral Dissertation). Open University. Retrieved from http://oro.open.ac.uk/52284/ ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367998

Chicago Manual of Style (16th Edition):

Mahnke, Yolanda Dagmar. “A novel model system for the study of anti-tumour T-cell memory.” 2001. Doctoral Dissertation, Open University. Accessed December 13, 2019. http://oro.open.ac.uk/52284/ ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367998.

MLA Handbook (7th Edition):

Mahnke, Yolanda Dagmar. “A novel model system for the study of anti-tumour T-cell memory.” 2001. Web. 13 Dec 2019.

Vancouver:

Mahnke YD. A novel model system for the study of anti-tumour T-cell memory. [Internet] [Doctoral dissertation]. Open University; 2001. [cited 2019 Dec 13]. Available from: http://oro.open.ac.uk/52284/ ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367998.

Council of Science Editors:

Mahnke YD. A novel model system for the study of anti-tumour T-cell memory. [Doctoral Dissertation]. Open University; 2001. Available from: http://oro.open.ac.uk/52284/ ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367998


UCLA

22. Lorenzini, Michael Hideo. Engineering Robust T-Cell Response Against Immunosuppressive Tumors.

Degree: Bioengineering, 2016, UCLA

 With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, efforts are growing to advance T-cell therapy for new indications, especially solid tumors.… (more)

Subjects/Keywords: Immunology; Biomedical engineering; Molecular biology; Adoptive cell therapy; Cancer immunosuppression; Cancer immunotherapy; CAR-T cells; Chimeric antigen receptor; TGF beta

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lorenzini, M. H. (2016). Engineering Robust T-Cell Response Against Immunosuppressive Tumors. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Thesis, UCLA. Accessed December 13, 2019. http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Web. 13 Dec 2019.

Vancouver:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Internet] [Thesis]. UCLA; 2016. [cited 2019 Dec 13]. Available from: http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Thesis]. UCLA; 2016. Available from: http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Victoria

23. Martin, Michele. Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment.

Degree: Dept. of Biology, 2011, University of Victoria

 In the era of personalized cancer treatment, adoptive T cell therapy (ACT) shows promise for the treatment of solid cancers. However, partial or mixed responses… (more)

Subjects/Keywords: adoptive cell therapy; breast cancer; tumor; transgenic mouse model; HER2/neu; immunotherapy; T cell; infiltration; bioinformatics; microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Martin, M. (2011). Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment. (Thesis). University of Victoria. Retrieved from http://hdl.handle.net/1828/3655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Martin, Michele. “Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment.” 2011. Thesis, University of Victoria. Accessed December 13, 2019. http://hdl.handle.net/1828/3655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Martin, Michele. “Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment.” 2011. Web. 13 Dec 2019.

Vancouver:

Martin M. Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment. [Internet] [Thesis]. University of Victoria; 2011. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/1828/3655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Martin M. Adoptive T cell therapy of breast cancer: defining and circumventing barriers to T cell infiltration in the tumour microenvironment. [Thesis]. University of Victoria; 2011. Available from: http://hdl.handle.net/1828/3655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

24. Ho, Patrick. Reprogramming T Cells to Interrogate Intracellular Disease Signatures.

Degree: Chemical Engineering, 2019, UCLA

Adoptive T-cell therapy—an emerging paradigm in which tumor-targeting T cells serve as living therapeutic modalities administered to cancer patients—has demonstrated remarkable curative potential in patients… (more)

Subjects/Keywords: Biomedical engineering; Immunology; Molecular biology; adoptive T-cell therapy; cytotoxicity; granzyme B; immunotherapy; intracellular antigen; synthetic biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ho, P. (2019). Reprogramming T Cells to Interrogate Intracellular Disease Signatures. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/24g8z91x

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ho, Patrick. “Reprogramming T Cells to Interrogate Intracellular Disease Signatures.” 2019. Thesis, UCLA. Accessed December 13, 2019. http://www.escholarship.org/uc/item/24g8z91x.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ho, Patrick. “Reprogramming T Cells to Interrogate Intracellular Disease Signatures.” 2019. Web. 13 Dec 2019.

Vancouver:

Ho P. Reprogramming T Cells to Interrogate Intracellular Disease Signatures. [Internet] [Thesis]. UCLA; 2019. [cited 2019 Dec 13]. Available from: http://www.escholarship.org/uc/item/24g8z91x.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ho P. Reprogramming T Cells to Interrogate Intracellular Disease Signatures. [Thesis]. UCLA; 2019. Available from: http://www.escholarship.org/uc/item/24g8z91x

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Virginia Commonwealth University

25. Saleem, Sheinei. ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells.

Degree: PhD, Microbiology & Immunology, 2013, Virginia Commonwealth University

 Although the physiological consequences of Notch signaling in hematopoiesis have been extensively studied, the differential effects of individual notch cleavage products remain to be elucidated.… (more)

Subjects/Keywords: ADAM10; Notch Signaling; Hematopoiesis; Myeloid derived suppressor cells; Mast cells; Adoptive immunotherapy; parasitic infections; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saleem, S. (2013). ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/3196

Chicago Manual of Style (16th Edition):

Saleem, Sheinei. “ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells.” 2013. Doctoral Dissertation, Virginia Commonwealth University. Accessed December 13, 2019. https://scholarscompass.vcu.edu/etd/3196.

MLA Handbook (7th Edition):

Saleem, Sheinei. “ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells.” 2013. Web. 13 Dec 2019.

Vancouver:

Saleem S. ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2013. [cited 2019 Dec 13]. Available from: https://scholarscompass.vcu.edu/etd/3196.

Council of Science Editors:

Saleem S. ADAM10 overexpression dysregulates Notch signaling in favor of myeloid derived suppressor cell (MDSC) accumulation that deferentially modulates the host response depending on immune stimuli and interaction with mast cells. [Doctoral Dissertation]. Virginia Commonwealth University; 2013. Available from: https://scholarscompass.vcu.edu/etd/3196


University of Illinois – Urbana-Champaign

26. Tosic, Vesna. Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors.

Degree: PhD, Molecular & Integrative Physi, 2015, University of Illinois – Urbana-Champaign

Immunotherapy in general and adoptive cell transfer in particular have recently been in the spotlight of cancer research. Recent FDA approval of the first immunotherapeutic… (more)

Subjects/Keywords: adoptive cell therapy; Interleukin-15 (IL-15) (IL15); poxvirus; myxoma virus; oncolytic virus; T cells; cancer; tumor; cancer immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tosic, V. (2015). Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/78313

Chicago Manual of Style (16th Edition):

Tosic, Vesna. “Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors.” 2015. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed December 13, 2019. http://hdl.handle.net/2142/78313.

MLA Handbook (7th Edition):

Tosic, Vesna. “Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors.” 2015. Web. 13 Dec 2019.

Vancouver:

Tosic V. Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2015. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/2142/78313.

Council of Science Editors:

Tosic V. Enhancing efficacy of oncolytic myxoma virus and adoptive T cell therapy against tumors. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2015. Available from: http://hdl.handle.net/2142/78313


Freie Universität Berlin

27. Wieczorek, Agnieszka. optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen.

Degree: 2013, Freie Universität Berlin

 Zuverlässige Methoden zur Induktion und In-vitro-Expansion von Antigen- spezifischen T-Zellen bilden die Grundlage zur Etablierung eines suffizienten adoptiven T-Zelltransfers von niedrig-frequenten oder sogar naiven T-Zellen.… (more)

Subjects/Keywords: CTL priming; antigen-specific T cells; adoptive immunotherapy CTL induction; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wieczorek, A. (2013). optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen. (Thesis). Freie Universität Berlin. Retrieved from https://refubium.fu-berlin.de/handle/fub188/12673

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wieczorek, Agnieszka. “optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen.” 2013. Thesis, Freie Universität Berlin. Accessed December 13, 2019. https://refubium.fu-berlin.de/handle/fub188/12673.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wieczorek, Agnieszka. “optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen.” 2013. Web. 13 Dec 2019.

Vancouver:

Wieczorek A. optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen. [Internet] [Thesis]. Freie Universität Berlin; 2013. [cited 2019 Dec 13]. Available from: https://refubium.fu-berlin.de/handle/fub188/12673.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wieczorek A. optimiertes Verfahren zur Gewinnung von antigen-spezifischen CD8 positiven T-Zellen. [Thesis]. Freie Universität Berlin; 2013. Available from: https://refubium.fu-berlin.de/handle/fub188/12673

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

28. Kruschinski, Anna. Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen.

Degree: 2011, Freie Universität Berlin

 NK-Zellen sind vielversprechende Effektoren im Hinblick auf adoptive Immuntherapie von Tumoren, vor allem wenn man auf Tumore mit wenig oder keiner MHC-Klasse-I-Expression abzielt. Trotzdem sind… (more)

Subjects/Keywords: cellular therapy; NK cells; HER-2; adoptive immunotherapy; chimeric receptor; 500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kruschinski, A. (2011). Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-7777

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kruschinski, Anna. “Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen.” 2011. Thesis, Freie Universität Berlin. Accessed December 13, 2019. http://dx.doi.org/10.17169/refubium-7777.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kruschinski, Anna. “Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen.” 2011. Web. 13 Dec 2019.

Vancouver:

Kruschinski A. Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen. [Internet] [Thesis]. Freie Universität Berlin; 2011. [cited 2019 Dec 13]. Available from: http://dx.doi.org/10.17169/refubium-7777.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kruschinski A. Entwicklung antigen-spezifischer primärer humaner NK-Zellen zur Bekämpfung von HER-2-positiven Karcinomen. [Thesis]. Freie Universität Berlin; 2011. Available from: http://dx.doi.org/10.17169/refubium-7777

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

29. Zimmermann, Andra. preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive.

Degree: 2015, Freie Universität Berlin

 INTRODUCTION Viral infections are often critical complications after allogeneic haematopoietic stem cell transplantation. Adenoviruses and herpesviruses are the most frequent and severe causes of opportunistic… (more)

Subjects/Keywords: Adenovirus; T cells; immunotherapy; adoptive; allogeneic; stem cell; transplantation; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zimmermann, A. (2015). preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive. (Thesis). Freie Universität Berlin. Retrieved from https://refubium.fu-berlin.de/handle/fub188/13249

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zimmermann, Andra. “preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive.” 2015. Thesis, Freie Universität Berlin. Accessed December 13, 2019. https://refubium.fu-berlin.de/handle/fub188/13249.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zimmermann, Andra. “preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive.” 2015. Web. 13 Dec 2019.

Vancouver:

Zimmermann A. preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive. [Internet] [Thesis]. Freie Universität Berlin; 2015. [cited 2019 Dec 13]. Available from: https://refubium.fu-berlin.de/handle/fub188/13249.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zimmermann A. preparation for clinical application in paediatric patients after allogeneic haematopoietic stem cell transplantation with complications by adenoviruses or preemptive. [Thesis]. Freie Universität Berlin; 2015. Available from: https://refubium.fu-berlin.de/handle/fub188/13249

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas – Austin

30. Ooi, Tracy Peksim. The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy.

Degree: PhD, Cell and Molecular Biology, 2014, University of Texas – Austin

Adoptive T cell transfer is a form of immunotherapy that has shown promise in treating several cancers and post-transplant lymphoproliferative diseases. This therapy relies on… (more)

Subjects/Keywords: Cytotoxic T cells; CD34+ cord blood; Notch ligands; MHC/HLA tetramers; T cell development; Adoptive T cell transfer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ooi, T. P. (2014). The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy. (Doctoral Dissertation). University of Texas – Austin. Retrieved from http://hdl.handle.net/2152/63851

Chicago Manual of Style (16th Edition):

Ooi, Tracy Peksim. “The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy.” 2014. Doctoral Dissertation, University of Texas – Austin. Accessed December 13, 2019. http://hdl.handle.net/2152/63851.

MLA Handbook (7th Edition):

Ooi, Tracy Peksim. “The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy.” 2014. Web. 13 Dec 2019.

Vancouver:

Ooi TP. The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy. [Internet] [Doctoral dissertation]. University of Texas – Austin; 2014. [cited 2019 Dec 13]. Available from: http://hdl.handle.net/2152/63851.

Council of Science Editors:

Ooi TP. The generation of antigen-specific CD8+ T cells from stem cells for adoptive transfer immunotherapy. [Doctoral Dissertation]. University of Texas – Austin; 2014. Available from: http://hdl.handle.net/2152/63851

[1] [2]

.